Non-Parkinson akinetic-rigid syndromes

Current Opinion in Neurology

Volumn 9, Issue 4, 1996, Pages 321-326

  Riley, David E ^a,c   Lang, Anthony E ^b  

^a Mt Sinai Medical Center Cleveland   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AKINESIA; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; PARKINSONISM; REVIEW;

EID: 0029768816     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199608000-00015     Document Type: Review

References (86)

1. Yamamoto T, Yamashita M: Thalamo-olivary degeneration in a patient with laryngopharyngeal dystonia. J Neurol Neurosurg Psychiatry 1995, 59:438-441.
2. Biary N, Madkour MM, Sharif H: Post-heatstroke parkinsonism and cerebellar dysfunction. Clin Neurol Neurosurg 1995, 97:55-57.
3. Verma A, Berger JR, Bowen BC, Sanchez-Ramos J: Reversible parkinsonian syndrome complicating cysticercus midbrain encephalitis. Mov Disord 1995, 10:215-219.
4. Nielsen JE, Jensen LN, Krabbe K: Hereditary haemochromatosis: a case Of iron accumulation In the basal ganglia associated with a parkinsonian syndrome. J Neurol Neurosurg Psychiatry 1995, 59:318-321.
5. Sempere AR Duarte J, Cabezas C, Coria F, Claveria LE: Parkinsonism induced by amlodipine [Letter], Mov Disord 1995,10:115-116,
6. Cardoso F, Jankovic J: Peripherally induced tremor and parkinsonism. Arch Neurol 1995, 52:263-270.
7. Mena MA, Garcia de Yebenes MJ, Tabernero C, Casarejos MJ, Pardo B, Garcia de Yebenes J. Effects of calcium antagonists on the dopamine system. Clin Neuropharmacol 1995, 18:410-426.
8. Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V: Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis. Neurology 1995, 45:1340-1344,
9. Remy P, Hosseini H, Degos JD, Samson Y, Agid Y, Warter JM, Vidailhet M: Striatal dopaminergic denervation in pallidopyramidal disease demonstrated by positron emission tomography. Ann Neurol 1995, 38:954-956.
10. Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN: Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 1995, 37:300-312.
11. Alexander NB, Mollo JM, Giordani B: Maintenance of balance, gait patterns, and obstacle clearance in Alzheimer's disease. Neurology 1995, 45:908-914.
12. Klatka LA, Schiffer RB, Powers JM, Kazec AM: Incorrect diagnosis of Alzheimer's disease. Arch Neurol 1996, 53:35-42.
13. Louis ED, Goldman JE, Powers JM, Fahn S: Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord 1995, 10:188-194.
14. Wszolek ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM, Uitti RJ, Calne DB, Pfeiffer RF: Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995, 45:502-505
15. Markopoulou K, Wszolek ZK, Pfeiffer RF: A Greek-American kindred with autosomal dominant levodopa-responsive parkinsonism and anticipation. Ann Neurol 1995, 38:373-378.
16. Kishore A, Vingerhoets BJ, Snow BJ, Arwert F, Wszolek ZK, Calne DB: Pre-synaptic nigrostriatal dysfunction predates clinical symptoms in carriers of the PPND gene [Abstract]. Can J Neurol Sci 1995, 22:S16.
17. Tuite PJ, Rogaeva EA, St. George-Hyslop PH, Lang AE: Dopa-responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion. Ann Neurol 1995, 38:684-687.
18. Ishikawa A, Miyatake T: A family with hereditary juvenile dystonia-parkinsonism. Mov Disord 1995, 10:482-488.
19. Zijlmans JC, Thijssen HO, Vogels OJ, Kremer HP, Poels PJ, Schoonderwaldt HC, Merx JL, van't Hof MA, Thien T, Horstink MW: MRI in patients with suspected vascular parkinsonism. Neurology 1995, 45:2183-2188.
20. Fenelon G, Gray F, Wallays C, Poirier J, Guillard A: Parkinsonism and dilatation of the perivascular spaces (etat crible) of the striatum: a clinical, magnetic resonance imaging, and pathological study. Mov Disord 1995, 10:754-760.
21. Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC: Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Mov Disord 1995, 10:450-454.
22. de la Fuente Fernandez R: Thalamic lacune and contralateral hemiparkinsonism subsequently relieved by spontaneous thalamo-subthalamic hematoma [Letter], Mov Disord 1995, 10:116-117.
23. Kulisevsky J, Avila A, Berthier ML: Bipolar affective disorder and unilateral parkinsonism after a brainstem infarction [Letter]. Mov Disord 1995, 10:799-801.
24. Remy P, de Recondo A, Defer G, Loc'h C, Amarenco P, Plante-Bordeneuve V, Dao Castellana MH, Bendriem B, Crouzel C, Clanet M et al: Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Neurology 1995, 45:472-477.
25. Shinotoh H, Snow BJ, Hewitt KA, Pate BD, Doudet D, Nugent R, Perl DP, Olanow W, Calne DB. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995, 45:1199-1204.
26. Rosenow F, Herholz K, Lanfermann H, Weuthen G, Ebner R, Kessler J, Ghaemi M, Heiss WD: Neurologic sequelae of cyanide intoxication - the patterns of clinical, magnetic resonance imaging, and positron emission tomography findings. Ann Neurol 1995, 38:825-828.
27. Pezzoli G, Antonini A, Barbieri S, Canesi M, Perbellini L, Zecchinelli A, Mariani CB, Bonetti A, Leenders KL: n-Hexane-induced parkinsonism: pathogenetic hypotheses. Mov Disord 1995, 10:279-282.
28. McCrank E: Parkinsonism secondary to petroleum exposure [Letter]. Neurology 1995, 45:2112.
29. Tetrud JW, Langston JW, Irwin I, Snow B: Parkinsonism secondary to petroleum exposure [Letter]. Neurology 1995, 45:2112.
30. Mott SH, Packer RJ, Vezina LG, Kapur S, Dinndorf PA, Conry JA, Pranzatelli MR, Quinones RR: Encephalopathy with parkinsonian features in children following bone marrow transplantations and high-dose amphotericin B. Ann Neural 1995, 37:810-814.
31. Holroyd S, Smith D: Disabling parkinsonism due to lithium: a case report J Genatr Psychiatry Neurol 1995, 8:118-119.
32. Dotti MT, Federico A: Amiodarone-induced parkinsonism: a case report and pathogenetic discussion [Letter]. Mov Disord 1995, 10:233-234.
33. Avorn J, Bohn RL, Mogun H, Gurwitz JH, Monane M, Everitt D, Walker A: Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. Am J Med 1995, 99:48-54. This is an important study highlighting the underdiagnosis of a major public health problem.
34. Coulter DM, Pillans PI: Fluoxetine and extrapyramidal side effects. Am J Psychiatry 1995, 152:122-125.
35. Montastruc JL, Fabre N, Blin O, Senard JM, Rascol O, Rascol A: Does fluoxetine aggravate Parkinson's disease? A pilot prospective study [Letter]. Mov Disord 1995, 10:355-357.
36. Kim JS, Choi IS, Lee MC: Reversible parkisonism and dystonia following probable mycoplasma pneumonias infection. Mov Disord 1995, 10:510-512.
37. Yoon SS, Chan S, Chin S, Lee K, Goodman RR: MRI of Creutzfeldt-Jakob disease: asymmetric high signal intensity of the basal ganglia. Neurology 1995, 45:1932-1933.
38. Lieberman A: Hitler, Parkinson's disease and history. BNI Quarterly 1995, 11:4-21.
39. Jog MS, Lang AE: Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord 1995, 10:714-722.
40. Davie CA, Pirtosek Z, Barker GJ, Kingsley DP, Miller PH, Lees AJ: Magnetic resonance spectroscopic study of parkinsonism related to boxing. J Neurol Neurosurg Psychiatry 1995, 58:686-691.
41. Friedman JH: Walking-induced parkinsonism due to presumed idiopathic normal pressure hydrocephalus [Letter]. Mov Disord 1995, 10:99-101.
42. Fabbrini G, Baronti F, Ruggieri S, Lenzi GL: Meningioma-induced loss of antiparkinsonian response to levodopa [Letter]. Mov Disord 1995, 10:231-232.
43. Tranchant C, Bhatia KP, Marsden CD: Movement disorders in multiple sclerosis. Mov Disord 1995, 10:418-423. This is an excellent review tying together a widely scattered literature.
44. Lang AE: Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome. Mov Disord 1995, 10:489-495.
45. Lang AE, Koller WC, Fahn S: Psychogenic parkinsonism. Arch Neurol 1995, 52:802-810.
46. Denson MA, Wszolek ZK: Familial parkinsonism: our experience and review. Parkinson Rel Dis 1995, 1:35-46. The authors provide a timely review of an important topic.
47. Critchley M: Arteriosclerotic parkinsonism. Brain 1929, 52:23-83.
48. Uitti RJ, Rajput TJ, Ashenhurst EM, Rodzilsky B: Cyanide-induced parkinsonism: a clinico-pathologic report Neurology 1985, 35:921-925.
49. Tetrud JW, Langston JW, Irwin I, Snow B: Parkinsonism caused by petroleum waste ingestion. Neurology 1994, 44:1051-1053.
50. Vingerhoets FJ, Snow BJ, Tetrud JW, Langston JW, Schulzer M, Calne DB: Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 1994; 36:765-770.
51. Victor M, Adams RD, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine 1965, 44:345-396.
52. Kulisevsky J, Pujol J, Deus J, Junque C, Balanzo J, Avila A, Capdevila A: Persistence of MRI hyperintensity of the globus pallidus in cirrhotic patients: a 2-year follow-up study. Neurology 1995, 45:995-997.
53. Wenning GK, Shephard B, Hawkes C, Petrukevitch A, Lees A, Quinn N: Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 1995, 91:247-250.
54. Rinne JO, Hublin C, Partinen M, Ruottinen H, Ruotsalainen U, Nagren K, Lehikoinen P, Laihinen A: Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol 1995, 37:568-573.
55. Penney JB: Multiple systems atrophy and nonfamilial olivopontocerebellar atrophy are the same disease [Editorial]. Ann Neurol 1995, 37:553-554.
56. Burn DJ, Rinne JO, Quinn NP, Lees AJ, Marsden CD, Brooks DJ: Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome. Brain 1995, 118:951-958.
57. Perani D, Bressi S, Testa D, Grassi F, Cortelli P, Gentrini S, Savoiardo M, Caraceni T, Fazio F: Clinical/metabolic correlations in multiple system atrophy. Arch Neurol 1995, 52:179-185.
58. Bordet R, Benhadjali J, Destee A, Belabbas A, Libersa C: Octreotide effects on orthostatic hypotension in patients with multiple system atrophy. Clin Neuropharmacol 1995, 18:83-89
59. Quinn NP, Wenning G, Marsden CD: The Shy-Drager syndrome. Arch Neurol 1995, 52:656-657,
60. Colisomo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ: Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995, 52:294-298.
61. Albanese A, Colisomo C, Bentivoglio AR, Fenici R, Melillo G, Colosimo C, Tonali P: Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry 1995, 59:144-151.
62. Goudier-Kouja N, Vadailhet M, Bonnet AM, Pichon J, Agid Y: 'Pure' striatonigral degeneration and Parkinson's disease; a comparative clinical study. Mov Disord 1995, 10:288-294,
63. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP: Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995, 58:160-166. This article contains the largest single MSA series with pathologic confirmation to date.
64. Wenning GK, Quinn NP, Daniel SE, Garratt H, Marsden CD: Facial dystonia in pathologically proven multiple system atrophy: a video report [Letter]. Mov Disord 1996, 11:107-109.
65. Magalhaes M, Wenning GK, Daniel SE, Quinn NP: Autonomie dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease - a retrospective comparison. Acta Neurol Scand 1995, 91:98-102. A high frequency of autonomie disturbances was found in Parkinson's disease patients, making clinical distinction from MSA difficult.
66. Quinn NP: Multiple system atrophy. In Movement disorders 3. Edited by Marsden CD. Fahn S. Oxford: Butterworth-Heinemann; 1994:262-281.
67. Pillon B, Blin J, Vidailhet M; Deweer B, Singu A, Dubois B, Agid Y: Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995, 58:174-179.
68. Iwahashi K, Miyatake R, Tsuneoka Y, Matsuo Y, Ichikawa Y, Hosokawa K, Sato K, Hayabara T: A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy [Letter]. J Neurol Neurosurg Psychiatry 1995, 58:263-264.
69. Davie CA, Wenning GK, Barker GJ, Tofts PS, Kendall BE, Quinn N, McDonald Wl, Marsden CD, Miller DH: Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995, 37:204-210.
70. Rascol O, Sabatini U, Fabre N, Senard JM, Simonetta-Moreau M, Montastruc JL, Clanet M, Rascol A: Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease. Mov Disord 1995, 10:163-170.
71. Daniel SE, Geddes JF, Revesz T: Glial cytoplasmic inclusions are not exclusive to multiple system atrophy [Letter]. J Neurol Neurosurg Psychiatry 1995, 58:262. This was an important pathologic finding, documenting glial cytoplasmic inclusions in other degenerative diseases, which was buried in the correspondence section.
72. Daniel SE, de Bruin VM, Lees AJ: The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995, 118:759-770 The authors present a large autopsy series with clinicopathologic correlation and furnish new insights into PSP.
73. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM: Progressive supranuclear palsy: neuropathologically based diagnostic criteria. J Neurol Neurosurg Psychiatry 1995, 58:167-173.
74. de Yebenes JG, Sarasa JL, Daniel SE, Lees AJ: Familial progressive supranuclear palsy. Brain 1995, 118:1095-1103. This article thoroughly documents one PSP family and contains a useful literature review.
75. Tabaton M, Rolleri M, Masturzo P, Cammarata S, Angelini G, Hansen LA, Saitoh T, Petersen RB, Perry G, Richey P et al.: Apolipoprotein E e4 allele frequency is not increased in progressive supranuclear palsy. Neurology 1995, 45:1764-1765.
76. MacKenzie IR, Hudson LP: Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol (Berlin) 1995, 90:615-619.
77. Valldeoriola F, Valls-Sole J, Tolosa ES, Marti MJ: Striated anal sphincter denervation in patients with progressive supranuclear palsy. Mov Disord 1995, 10:550-555.
78. Defebvre L, Lecouffe P, Destee A, Houdart P, Steinling M: Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease. Acta Neurol Scand 1995, 92:235-241.
79. Rey GJ, Tomer R, Levin BE, Sanchez-Ramos J, Bowen B, Bruce BH: Psychiatric symptoms, atypical dementia, and left visual field inattention In corticobasal ganglionic degeneration. Mov Disord 1995, 10:106-110.
80. Caselli RJ, Reiman EM, Timmann D, Stelmach GE, Lawson MA, Osborne D, Moore SB, Cevette MJ: Progressive apraxia in clinically discordant monozygotic twins. Arch Neurol 1995, 52:1004-1010.
81. Brunt ER, van Weerden TW, Pruim J, Lakke JW: Unique myoclonic pattern in corticobasal degeneration. Mov Disord 1995, 10:132-142.
82. Markus HS, Lees AJ, Lennox G, Marsden CD, Costa DC: Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT. Mov Disord 1995, 10:179-187.
83. Okuda B, Tachibana H. Cerebral blood flow in corticobasal degeneration [Letter]. Mov Disord 1995, 10:803.
84. Feany MB, Dickson DW: Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995, 146:1388-1396 This is a landmark study of the pathology of CBGD that describes many new findings and has altered our knowledge of the pathology of CBGD substantially
85. Nishimura T, Ikeda K, Akiyama H: Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy. Neurosci Lett 1995, 201:123-126.
86. Ksiezak-Reding H, Morgan K, Mattiace LA, Davies P, Liu WK, Yen SH, Weidenheim K, Dickson DW: Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 1994, 145:1496-1508.